ERCC1 and cancer: showed the association between high levels of ERCC1 expression and cisplatin resistance in cancer therapy.[40] The basis for this is that increased ERCC1 expression levels is associated with increased NER repair capacity which effectively reverse the effects of platinum‐DNA adducts.